The Gateway to Your Orthopaedic Recovery.

Author listing

Meet our authors and contributors and explore their latest articles, insights, and expertise
Editor-in-Chief

Editor-in-Chief 's Latest Stories

Total study duration up to 74 weeks: screening up to 4 weeks, AID assessment phase 12 weeks, extension phase 52 weeks, post-treatment follow-up of 6 weeks. For patients not entering the extension phas...
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of two dosing regimens of multiple, subcutaneous (sc) injections of ASP2408 in patients with Rheumatoid Arthri...
Conditions : Rheumatoid Arthritis; Targeted Ultrasound Intervention : Drug: Adalimumab Sponsors : University of Leeds; AbbVie; Theorem Recruiting - verified February 2014
Conditions : Psoriasis Vulgaris,; Psoriatic Arthritis,; Pustular Psoriasis,; Psoriatic Erythroderma Interventions : Drug: KHK4827 140mg SC; Drug: KHK4827 210mg SC Sponsor : Kyowa Hakko Kirin Company,...
Conditions : Osteoarthritis of the Shoulder; Complexe Proximal Humeral Fractures Intervention : Procedure: Shoulder replacement surgery Sponsor : Balgrist University Hospital Not yet recruiting - veri...
All patients were performed digital radiographs which one-leg and both-leg standing anteroposterior view. Medial and lateral joint space width were measured. The severity of OA knee was identified by...
Condition : Rheumatoid Arthritis Intervention : Sponsor : Rockefeller University Recruiting - verified January 2014
Conditions : Osteoarthritis; Rotator Cuff Tear Arthropathy; Reverse Total Shoulder Arthroplasty; Scapular Notching Intervention : Sponsors : The Cleveland Clinic; Eric Ricchetti Not yet recruiting - v...
Conditions : Osteoarthritis Knee; Total Knee Replacement Intervention : Procedure: Total Knee Arthroplasty Sponsor : Corporacion Parc Tauli Recruiting - verified January 2014
Condition : Rheumatoid Arthritis Intervention : Drug: ABT-494 Sponsor : AbbVie Recruiting - verified January 2014